Nuvectis Pharma (NVCT) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.35
-0.31
-0.28
-0.24

Details

Expected EPS
-0.254
Actual EPS
-0.27
Surprise EPS
-0.02
Surprise Percent
+6.3%

Description

Nuvectis Pharma (NVCT) has reported earnings of -0.27 per share for Q2 2025.

0 Comments

Share your thoughts